Pelvic Lymphadenectomy and Brachytherapy for Prostatic Cancer
- 1 January 1986
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 12 (4) , 265-269
- https://doi.org/10.1159/000472633
Abstract
Pelvic lymphadenectomy and interstitial radiotherapy of the prostate for early carcinoma is a procedure with a significant postoperative morbidity, depending on the extent of dissection, type of drainage, and use of heparin. Hematoma and lymphocele formation seems to be promoted by heparin. Limited lymph node dissection, appropriate, drainage, and the abandonment of heparin for prophylaxis of thromboembolism can reduce the complications associated with pelvic lymphadenectomy.This publication has 17 references indexed in Scilit:
- Staging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus BenefitJournal of Urology, 1980
- Pelvic Lymphadenectomy in the Management of Carcinoma of the ProstateJournal of Urology, 1980
- Effect of Mini-Dose Heparin on Lymphocele Formation Following Extraperitoneal Pelvic LymphadenectomyJournal of Urology, 1980
- Mini-dose heparin therapy in pelvic lymphadenectomy and 1251I implantation for localized prostatic cancerUrology, 1980
- Complications of pelvic lymphadenectomy and retropubic prostatic 125I implantationUrology, 1979
- Extended Pelvic Lymphadenectomy for Prostatic CancerJournal of Urology, 1979
- Morbidity of pelvic lymphadenectomyUrology, 1979
- Complications of 125 Iodine Implantation and Pelvic Lymphadenectomy in the Treatment of Prostatic CancerJournal of Urology, 1979
- HEPARIN-INDUCED THROMBOCYTOPENIA, THROMBOSIS, AND HEMORRHAGE1979
- COAGULATION PROPERTIES OF HUMAN THORACIC DUCT LYMPHThe Lancet Healthy Longevity, 1967